AbbVie
ABBV
#31
Rank
$316.03 B
Marketcap
$178.91
Share price
1.62%
Change (1 day)
15.89%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $316.03 Billion

As of March 2024 AbbVie has a market cap of $316.03 Billion. This makes AbbVie the world's 31th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2024

End of year Market Cap

Year Market cap Change
2024$316.03 B15.51%
2023$273.60 B-4.27%
2022$285.80 B19.4%
2021$239.37 B26.54%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On Mar 2nd, 2024 the market cap of AbbVie was reported to be:

$316.03 Billion
by Yahoo Finance info icon info icon
$316.03 Billion
by CompaniesMarketCap info icon info icon
$316.03 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$150.14 B-52.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$743.14 B 135.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$150.23 B-52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.11 B-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.08 B-71.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$102.90 B-67.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$201.47 B-36.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
$86.19 B-72.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
$13.06 B-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA